510(k) Report

510(k) · Cleared

Cleared

Epley Omniax

K071973510(k) TraditionalCleared Jun 20, 2008339-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vesticon · LXV Apparatus, Vestibular Analysis

Cleared on Jun 20, 2008 as substantially equivalent to K964325 (Micromedical Technologies, Inc., 1997) and 3 other predicates after a 339-day review. Its family tree reaches back 2 generations to 1995. 3 later devices descend from it.

Decided
Jun 20, 2008
Review
339 days
Class
Class U
Product code
LXV
Recalls
None
Predicates
4

Its longest line of descent runs back 2 generations to K946229 (1995). 5 ancestors in all, the oldest K863424 (1987). 3 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1997: 1 other ancestor1992: 1 other ancestor1987: 1 other ancestor2008: 1 descendant cleared2020: 1 descendant cleared2022: 1 descendant clearedK946229 · Balance Manager · Neurocom International, Inc. · 1995K070085 · Balance Rehabilitation Unit (Bru) · Medicaa (Uruguay) S.A. · 20071990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 3 other ancestors 1 generation forward: 3 descendants K070085 · Balance Rehabilitation Unit (Bru) · Medicaa (Uruguay) S.A. · 2007K946229 · Balance Manager · Neurocom International, Inc. · 19950
  1. Root · 2 generations backK946229 Balance ManagerNeurocom International, Inc. · 1995
  2. 1 generation backK070085 Balance Rehabilitation Unit (Bru)Medicaa (Uruguay) S.A. · 2007
  3. This deviceK071973 Epley OmniaxVesticon · 2008
  4. Descendant · cites it directly · 0 of its ownK220231 GyroStimUltrathera Technologies, Inc. · 2022
  5. Descendant · cites it directly · 0 of its ownK192652 TRVInteracoustics A/S · 2020
  6. Descendant · cites it directly · 0 of its ownK081602 DizzyfixClearwater Clinical Limited · 2008

Most influential descendants

Showing 3 of 3 · See all
  • K220231GyroStimUltrathera Technologies, Inc. · 2022 · cites it directly0descendants
  • K192652TRVInteracoustics A/S · 2020 · cites it directly0descendants
  • K081602DizzyfixClearwater Clinical Limited · 2008 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K946229Balance ManagerNeurocom International, Inc.1995—
−1K070085Balance Rehabilitation Unit (Bru)Medicaa (Uruguay) S.A.2007—
0 (this device)K071973Epley OmniaxVesticon2008—
+1K220231GyroStimUltrathera Technologies, Inc.2022—
+1K192652TRVInteracoustics A/S2020—
+1K081602DizzyfixClearwater Clinical Limited2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199210
199710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
202010
202210
FIG. 1 — Lineage of K071973, 1995–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LXV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LXV device

  1. #1 K220231 GyroStimscore 3.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K964325Visualeyes: Video Eye Monitor
Summary page 1
…lar analysis apparatus, LXV, unclassified and Nystagmograph, GWN, 882.1460, Class 11. Legally marketed device for substantial equivalence comparison: K(964325 - VisualEyes from MicroMedical Technologies, Inc. K863424 - Computer Eye Tracking System/ENG Exam Chair/Table from MicroMe…
Micromedical Technologies, Inc.1997—
*K863424Computer Eye Tracking Sys./Eng Exam. Chair & Table
Summary page 1
…graph, GWN, 882.1460, Class 11. Legally marketed device for substantial equivalence comparison: K(964325 - VisualEyes from MicroMedical Technologies, Inc. K863424 - Computer Eye Tracking System/ENG Exam Chair/Table from MicroMedical Technologies, Inc. K(922037 - System 2000…
Micromedical Technologies, Inc.1987—
*K922037System 2000, Rotational Vestibular Chair
Summary page 1
…isualEyes from MicroMedical Technologies, Inc. K863424 - Computer Eye Tracking System/ENG Exam Chair/Table from MicroMedical Technologies, Inc. K(922037 - System 2000 from MicroMedical Technologies, Inc. K(070085 - Balance Rehabilitation Unit from Medicaa, S.A. Description…
Micromedical Technologies, Inc.1992—
*K070085Balance Rehabilitation Unit (Bru)
Summary page 1
…puter Eye Tracking System/ENG Exam Chair/Table from MicroMedical Technologies, Inc. K(922037 - System 2000 from MicroMedical Technologies, Inc. K(070085 - Balance Rehabilitation Unit from Medicaa, S.A. Description of the device: The Epley Omniax is a multi-axial positional…
Medicaa (Uruguay) S.A.2007—

Also cleared against K964325: 5 other devices →

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K220231GyroStimUltrathera Technologies, Inc.20220
K192652TRVInteracoustics A/S20200
K081602DizzyfixClearwater Clinical Limited20080

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 11.6 years on median.
  • None of the 5 ancestors has a recall.
  • Of its descendants, K220231 (Ultrathera Technologies, Inc., 2022) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K964325.

How does its category compare?

All LXV devices

LXV Apparatus, Vestibular Analysis: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · LXV

1in 2022

2007: 22008: 22009: 12010: 12012: 12018: 12019: 22020: 22022: 1
2007high 2 (2007) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LXV

Too few LXV 510(k)s in any year since 2007 to give a median.

Recalls per year · LXV

1in 2009

2008: 12009: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LXV

1in 2010

2007: 12010: 1
2007high 1 (2007) · low 0 (2008)2025

MAUDE reports naming product code LXV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—01
20082—10
20091—10
20101—01
20110—00
20121—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20192—00
20202—00
20210—00
20221—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Epley Omniax is intended to assist in the diagnosis and treatment of balance disorders and vertigo, including benign paroxysmal positional vertigo.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071973: Epley Omniax.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K071973

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026